96 related articles for article (PubMed ID: 3617610)
1. [Immunocorrective therapy in esophageal cancer].
Baisheva SA; Zhalgasbaeva GT; Sysoeva MI; Asanov AA; Dil'man VM
Vopr Onkol; 1987; 33(7):38-43. PubMed ID: 3617610
[TBL] [Abstract][Full Text] [Related]
2. [The immune homeostasis of patients with prostatic cancer on hormonal chemotherapy, radiation treatment and immunological action].
Panteleeva ES; Sviridova TV; Neprina GS; Sirotkina NP
Urol Nefrol (Mosk); 1996; (1):28-31. PubMed ID: 8659039
[TBL] [Abstract][Full Text] [Related]
3. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of concurrent chemoradiation therapy for primary highly advanced esophageal cancer].
Kobayashi K; Fujitani K; Tsujinaka T; Kikkawa N
Gan To Kagaku Ryoho; 2001 Jul; 28(7):961-4. PubMed ID: 11478145
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
Bedenne L; Michel P; Bouché O; Milan C; Mariette C; Conroy T; Pezet D; Roullet B; Seitz JF; Herr JP; Paillot B; Arveux P; Bonnetain F; Binquet C
J Clin Oncol; 2007 Apr; 25(10):1160-8. PubMed ID: 17401004
[TBL] [Abstract][Full Text] [Related]
7. [Adrenal cortical function, immunological reactivity and the blood serum cholesterol level of esophageal cancer patients].
Khan OG; Baisheva SA; Togaĭbaeva ZI; Sysoeva MI
Vopr Onkol; 1987; 33(12):38-43. PubMed ID: 3424704
[TBL] [Abstract][Full Text] [Related]
8. [Perioperative multi-modality treatment strategies in esophageal cancer].
Porschen R
Z Gastroenterol; 1993 Nov; 31(11):680-5. PubMed ID: 8291282
[TBL] [Abstract][Full Text] [Related]
9. [Chemoradiation therapy for advanced esophageal cancers--report of 3 cases].
Yoshida S; Todoroki T; Koike N; Maruyama T; Kawamoto T; Fukao K; Shimizu W; Ohara K; Monoi H; Yamamoto Y; Kawai Y
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1343-7. PubMed ID: 10478190
[TBL] [Abstract][Full Text] [Related]
10. [Multidisciplinary preoperative treatment of esophageal cancer].
Ikebe M; Kuwano H; Maekawa S; Sugimachi K
Gan To Kagaku Ryoho; 1994 Mar; 21(4):425-30. PubMed ID: 8129382
[TBL] [Abstract][Full Text] [Related]
11. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
Bedenne L
Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
[TBL] [Abstract][Full Text] [Related]
12. [Cancers of the esophagus. Combined modality therapy by radiotherapy, chemotherapy with or without surgery].
Calais G; Bedenne L
Bull Cancer Radiother; 1995; 82(2):137-46. PubMed ID: 7546884
[No Abstract] [Full Text] [Related]
13. [Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer].
Shibata S; Kawasaki H; Nakai M; Morohashi H; Matsuya H; Yamada K; Morita T; Sasaki M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2209-12. PubMed ID: 12484039
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative synchronized chemoradiation therapy for advanced esophageal cancer].
Tsujinaka T; Takami M; Takada T; Kitada M; Tsukahara Y; Shibata T; Niinobu T; Murotani M; Iihara K; Tsukamoto F; Ogawa M; Kimura M; Nose T
Gan To Kagaku Ryoho; 1997 Mar; 24(5):557-61. PubMed ID: 9087287
[TBL] [Abstract][Full Text] [Related]
15. [The immunomodulating role of indomethacin in the chemoradiation treatment of inoperable patients with lung cancer].
Kas'ianenko IV; Pivniuk VM; Lisitsa AM; Kovalenko NA; Bagirian MA
Vopr Onkol; 1992; 38(10):1183-7. PubMed ID: 1343143
[TBL] [Abstract][Full Text] [Related]
16. [Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
Morishima Y; Tashiro T; Yamamori H; Takagi K; Ohtsubo Y; Sugiura T; Hayashi N; Furukawa K; Itabashi T; Sano W; Toyoda Y; Nitta H; Nakajima N
Gan To Kagaku Ryoho; 1997 Jun; 24(8):965-9. PubMed ID: 9212805
[TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal treatment of esophageal cancer].
Isono K
Kango Gijutsu; 1986 Jul; 32(9):1090-5. PubMed ID: 3637382
[No Abstract] [Full Text] [Related]
19. [Effectiveness of immunomodulators in multimodal treatment of patients with lung cancer].
Vagner VP; Voĭtkevich EG; Zakora GI; Chirvina ED
Klin Med (Mosk); 1991 Dec; 69(12):55-9. PubMed ID: 1787682
[TBL] [Abstract][Full Text] [Related]
20. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Narumiya K; Takasaki K; Mitsuhashi M
Gan To Kagaku Ryoho; 2003 Jun; 30(6):803-7. PubMed ID: 12852347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
